Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$0.17 - $0.26 $4,330 - $6,622
-25,471 Reduced 99.86%
36 $0
Q2 2022

Aug 15, 2022

BUY
$0.2 - $0.61 $5,094 - $15,537
25,471 Added 70752.78%
25,507 $5,000
Q1 2022

May 12, 2022

SELL
$0.48 - $0.74 $4,835 - $7,454
-10,073 Reduced 99.64%
36 $0
Q4 2021

Feb 14, 2022

SELL
$0.7 - $1.94 $3,919 - $10,862
-5,599 Reduced 35.64%
10,109 $7,000
Q3 2021

Nov 15, 2021

BUY
$1.82 - $5.71 $28,159 - $88,345
15,472 Added 6555.93%
15,708 $28,000
Q2 2021

Aug 16, 2021

SELL
$5.22 - $7.33 $856 - $1,202
-164 Reduced 41.0%
236 $1,000
Q1 2021

May 17, 2021

SELL
$4.0 - $10.28 $72,256 - $185,697
-18,064 Reduced 97.83%
400 $3,000
Q4 2020

Feb 16, 2021

BUY
$2.43 - $4.68 $44,867 - $86,411
18,464 New
18,464 $67,000

Others Institutions Holding HEXO

About HEXO Corp.


  • Ticker HEXO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 601,395,008
  • Description
  • HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up b...
More about HEXO
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.